γ-secretase inhibition combined with cisplatin enhances apoptosis of nasopharyngeal carcinoma cells

B BrennanNasopharyngeal carcinomaOrphanet J Rare Dis123200610.1186/1750-1172-1-23

S AfqirN IsmailiH ErrihaniConcurrent chemoradiotherapy in the management of advanced nasopharyngeal carcinoma: current statusJ Can Res Ther537200910.4103/0973-1482.4876319293481

RA AlbiruniRazakL LillianFF LiuE ItoB O’SullivanK ChanNasopharyngeal carcinoma: the next challengesEur J Cancer4619671978201010.1016/j.ejca.2010.04.004

SM ChenJP LiuJX ZhouSuppression of the notch signaling pathway by γ-secretase inhibitor GSI inhibits human nasopharyngeal carcinoma cell proliferationCancer Lett30676842011

J GuigayAdvances in nasopharyngeal carcinomaCurr Opin Oncol20264269200810.1097/CCO.0b013e3282fad84618391624

HM LuaLX PangXB YuanConcurrent chemoradiotherapy in locally advanced nasopharyngeal carcinoma: a treatment paradigm also applicable to patients in Southeast AsiaCancer Treat Rev35345353200910.1016/j.ctrv.2009.01.00219211192

M KartalouJM EssigmannMechanisms of resistance to CisplatinMutat Res4782343200110.1016/S0027-5107(01)00141-511406167

F GuY MaZ ZhangJ ZhaoH KobayashiL ZhangL FuExpression of Stat3 and Notch1 is associated with cisplatin resistance in head and neck squamous cell carcinomaOncol Rep23671676201020127005

ZW WangYW LiA AhmadTargeting Notch signaling pathway to overcome drug resistance for cancer therapyBiochim Biophys Acta182582672010

S Artavanis-TsakonasMD RandRJ LakeNotch signaling: cell fate control and signal integration in developmentScience284770776199910.1126/science.284.5415.77010221902

T KadeschNotch signaling: the demise of elegant simplicityCurr Opin Genet14506512200410.1016/j.gde.2004.07.00715380241

R KopanMX IlaganThe canonical Notch signaling pathway: unfolding the activation mechanismCell137216233200910.1016/j.cell.2009.03.04519379690

IM ShihTL WangNotch signaling, γ-secretase inhibitors, and cancer therapyCancer Res67187918822007

J SarahNotch signaling: a simple pathway becomes complexNat Rev Mol Cell Biol7678687200610.1038/nrm200916921404

T AleksicM StephanGamma-secretase inhibition combined with platinum compounds enhances cell death in a large subset of colorectal cancer cellsCell Commun Signal6113200810.1186/1478-811X-6-818950493

G SzakacsJK PatersonJA LudwigC Booth-GentheMM GottesmanTargeting multidrug resistance in cancerNat Rev Drug Discov5219234200610.1038/nrd198416518375

MM GottesmanMechanisms of cancer drug resistanceAnn Rev Med5615627200210.1146/annurev.med.53.082901.103929

Z WangY LiD KongA AhmadS BanerjeeFH SarkarCross-talk between miRNA and Notch signaling pathways in tumor development and progressionCancer Lett292141148201010.1016/j.canlet.2009.11.01220022691

Z WangY LiS BanerjeeFH SarkarEmerging role of Notch in stem cells and cancerCancer Lett279812200910.1016/j.canlet.2008.09.03019022563

LL SuC Yan-ChengD DoloresDrug transporter, P-glycoprotein (MDR1), is an integrated component of the mammalian blood-testis barrierInt J Biochem Cell Biol4125782587200910.1016/j.biocel.2009.08.01519720156

XB ChangA molecular understanding of ATP-dependent solute transport by multidrug resistance-associated protein MRP1Cancer Metastasis Rev261537200710.1007/s10555-007-9041-717295059

Y HuangX YangY Wuγ-secretase inhibitor induces adipogenesis of adipose-derived stem cells by regulation of Notch and PPAR-γCell Prolif431471562010

L BorgheseD DolezalovaT OpitzInhibition of Notch signaling in human embryonic stem cell-derived neural stem cells delays G1/S phase transition and accelerates neuronal differentiation in vitro and in vivoStem Cells28955964201010.1002/stem.40820235098

RL FineTC ChambersCW SachsP-glycoprotein, multidrug resistance and protein kinase CStem Cells144755199610.1002/stem.1400478820951

K KirschnerDW MeltonMultiple roles of the ERCC1-XPF endonuclease in DNA repair and resistance to anticancer drugsAnticancer Res3032233232201020944091

J BellmuntL Paz-AresM CuelloGene expression of ERCC1 as a novel prognostic marker in advanced bladder cancer patients receiving cisplatin-based chemotherapyAnn Oncol18522528200710.1093/annonc/mdl43517229776

KA OlaussenA DunantP FouretDNA repair by ERCC1 in non-small-cell lung cancer and cisplatin-based adjuvant chemotherapyN Engl J Med355983991200610.1056/NEJMoa06057016957145

QE WangK MilumCH HanDifferential contributory roles of nucleotide excision and homologous recombination repair for enhancing cisplatin sensitivity in human ovarian cancer cellsMol Cancer1024201110.1186/1476-4598-10-24

Y NefedovaM DanielCB SophiaSD WilliamIG DmitryInhibition of Notch signaling induces apoptosis of myeloma cells and enhances sensitivity to chemotherapyBlood11122202228200810.1182/blood-2007-07-10263218039953

S KoduruR KumarS SrinivasanNotch-1 inhibition by Withaferin-A: a therapeutic target against colon carcinogenesisMol Cancer Ther9202210201010.1158/1535-7163.MCT-09-077120053782